Author

T. El‐Galaly

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Beyond maximum grade: key regulatory considerations in adverse event reporting.

Key challenges and opportunities related to measuring cumulative and long-term toxicity burden, incorporating patient-reported outcomes, improving adverse event reporting quality and efficiency in clinical trials, and leveraging real-world data, registries, and emerging technologies, such as artificial intelligence and...

Kyriaki Tzogani, T. El-Galaly, N. Everest et al. · The Lancet Haematology · 2 citations

Open access Aug 2026

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

This White Paper written by the Global Lymphoma Registry Alliance (LyRA) discusses the importance and value of lymphoma registries for different stakeholders as well as benefits of forming a global alliance of the registry network.

Eliza A. Hawkes, E. Chung, M. Bishton et al. · Haematologica · 0 citations